TMS in Borderline Personality Disorder Patients
- Conditions
- Borderline Personality Disorder
- Interventions
- Device: Right r TMS 1 HzDevice: Left rTMS 5 Hz
- Registration Number
- NCT02273674
- Lead Sponsor
- Instituto Nacional de Psiquiatría Dr. Ramón de la Fuente
- Brief Summary
The purpose of this study is to determine the potential effects of repetitive transcranial magnetic stimulation in the improvement of neuropsychological deficits and symptomatology in borderline personality disorder patients. Specially in cognitive flexibility, inhibition control and social cognition.
- Detailed Description
This is a randomized, parallel group clinical trial to evaluate the efficacy of two protocols of repetitive Transcranial Magnetic Stimulation (rTMS), the application will be over dorsolateral prefrontal cortex (DLPFC) right and left, in patients with borderline personality disorder. 40 ambulatory patients with a borderline personality disorder diagnosis from the National Institute of Psychiatry in México will be included. All Patients will be randomly assigned and will complete a total of 23 sessions rTMS, in any of two groups:
5 Hz Group.- This group will receive rTMS sessions, 5 per week during three weeks (acute treatment phase), and after that, one session a week for the next eight weeks (follow up). The rTMS will be applied over the left DLPFC at 5 Hz, 1500 pulses per session in 100% of Motor threshold
1 Hz Group.- This group will receive rTMS sessions, 5 per week during three weeks (acute treatment phase), and after that, one session a week for the next eight weeks (follow up).
The rTMS will be applied over the right DLPFC at 1 Hz, 900 pulses per session in 100% of Motor threshold All sessions will be applied with a "Dantec" transcranial magnetic stimulator. The affective, borderline and anxiety symptoms will be evaluated at baseline, and every 5 TMS sessions during the acute treatment phase, and once at the end of the 8-weeks follow up. In same form for neuropsychological evaluations .
Categorical variables will be described by percentages and frequencies. Continuous variables will be described by means and standard deviations. Treatment groups will be compared using Student's T test. Cognitive, anxiety, borderline and affective symptom scale scores between treatment groups will be compared using repeated measures ANOVA
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 40
- Diagnosis of borderline personality disorder according to diagnostic and statistical manual of mental disorders IV text revision
- Treatment with selective inhibitors of serotonin reuptake
- Mass corporal index more than 19
- Suicide risk or suicide attempt recent or actual
- History of epilepsy or seizures
- History of cranial trauma with loss awareness
- Intracranial or intraocular ferromagnetic devices, including skull prosthesis.
- Pregnant womens.
- Neurosurgery, cardiac pacemaker, lefthander
- Patients with psychotic symptoms, bipolar disorder or substance addiction.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Right r TMS 1 Hz Right r TMS 1 Hz This group receive transcranial magnetic stimulation at 1 Hz of frequency over right dorsolateral prefrontal cortex. Once a day on monday to friday. Until receive 15 sessions. After this the subjects, will be received 8 more sessions of TMS, one session at week for next eight weeks Left rTMS 5 Hz Left rTMS 5 Hz This group receive transcranial magnetic stimulation at 5 Hz of frequency over left dorsolateral prefrontal cortex. Once a day on monday to friday. Until receive 15 sessions. After this the subjects, will be received 8 more sessions of TMS, one session at week for next eight weeks
- Primary Outcome Measures
Name Time Method Change from Baseline in BORDERLINE EVALUATION OF SEVERITY OVER TIME (BEST) Inclusion, after 15 days of treatment and at 8 weeks follow up The Borderline Evaluation of Severity Over Time (BEST) was developed to rate the thoughts, emotions, and behaviors typical of borderline personality disorder.
- Secondary Outcome Measures
Name Time Method Change from Baseline in Hamilton Depression rating scale Inclusion, after 15 days of treatment and at 8 weeks follow up The Hamilton depression rating scale is a is a multiple item questionnaire used to provide an indication of depression, and as a guide to evaluate recovery
Change from Baseline in Stop Signal Task (SST) Inclusion, after 15 days of treatment and at 8 weeks follow up SST measuring response inhibition (impulse control). The subject must respond to an arrow stimulus, by touching either of two choices depending on the direction in which the arrow points. If an audio tone is present, the subject must inhibit that response.
Change from Baseline in Wisconsin card sorting test (WCST) Inclusion, after 15 days of treatment and at 8 weeks follow up WCST is used primarily to assess perseveration and abstract thinking, the WCST is also considered a measure of executive function because of its reported sensitivity to frontal lobe dysfunction.
Change from Baseline in Reading the Mind in the Eyes Test Inclusion, after 15 days of treatment and at 8 weeks follow up The 'Reading the Mind in the Eyes' (Eyes) test is an advanced test of theory of mind. It is widely used to assess individual differences in social cognition and emotion recognition across different groups and cultures.
Change from Baseline in Barratt impulsiveness scale IInclusion, after 15 days of treatment and at 8 weeks follow up The Barratt Impulsiveness Scale is a questionnaire designed to assess the personality/behavioral construct of impulsiveness.
Trial Locations
- Locations (1)
Instituto Nacional de Psiquiatria Ramon de la Fuente
🇲🇽Mexico Distrito Federal, Mexico